Novavax, Inc.
NVAX$11.26−11.41% 1D
$6.2052-week range$13.39
Updated . Prices are snapshots and may be delayed.
Novavax, Inc. price chart
−10.45% over 7D
$13.14
$11.06
Oct 18
Oct 20
AI Outlook for Novavax, Inc.
Bullish posture- Long-term trend+17.8% vs 200-day average
- Medium-term trend+7.3% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Novavax, Inc. performance
1D
−11.4%
7D
−12.7%
30D
+9.3%
90D
+36.8%
1Y
+29.8%
About Novavax, Inc.
Novavax, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 1973 (ticker NVAX).
The shares trade at a price-to-earnings ratio of 3.9.
Novavax, Inc. market data
What is the price of Novavax, Inc. today?
Novavax, Inc. (NVAX) is at $11.26, −11.41% on the day.
What is the 52-week range of Novavax, Inc.?
Over the past year Novavax, Inc. has traded between $6.20 and $13.39. It is currently 70% of the way up that range.
What is the P/E ratio of Novavax, Inc.?
Novavax, Inc. trades at a price-to-earnings ratio of 3.9.
Similar stocks
MRNA
Moderna Inc
$218.01−7.2%
IBRX
Immunitybio Inc
$9.18−8.4%
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.47−15.7%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$2.63−6.4%
MDXH
MDxHealth SA
$0.2066−48.4%
SLS
SELLAS Life Sciences Group, Inc.
$9.98−10.9%
IOVA
Iovance Biotherapeutics, Inc.
$13.62−7.0%
PURR
Hyperliquid Strategies Inc.
$9.07−5.6%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.